Patient Note — 266860

progress_notes_266860_1_deid.txt

← Back to all patients Run PA Decision for this patient →

Demographics & Encounter

Patient ID266860 (PHI redacted)
Age / Gender82 / Female
Date of Service2026-03-27
Provider[PROVIDER_NAME]
FacilityPOTOMAC UROLOGY CENTER - Manassas
PayerHighmark Medicare
Reason1. Microscopic Hematuria

Diagnoses

R31.29 Microscopic hematuria
N32.81 OAB (overactive bladder)

Medications

Trelegy Ellipta Levothyroxine Sodium Estradiol Pantoprazole Sodium Entresto PARoxetine HCl Metoprolol Succinate ER Ibandronate Sodium Medication List reviewed and reconciled with the patient

Past Medical History

  • Thyroid disease
  • Depression

Vitals

RR 16.0
HR 69.0
BP 108/65
BMI 28.71
WEIGHT 147 lbs
HEIGHT_IN 60.0

Clinical Summary (HPI)

General Urology: 82y F NPC presents today for microscopic hematuria. Reports urinary frequency and urgency - not bothesome. No hx of kidney stones. She reports spasms. Never smoker. ----------------------------------------- Labs (02/2026): Cr 0.7 UAmicro (03/2026): WBC 40-60, RBC 3-10, Bac Many, CaOx Crystal UCX: Normal.

Raw Note (de-identified preview)

4/16/26, 12:31 AM Print Preview [PATIENT_NAME] DOB: [DOB] (82 yo F) Acc No. [ACCOUNT_ID] DOS: 03/27/2026 [PATIENT_NAME] 82 Y old Female, DOB: [DOB] Account: [ACCOUNT_ID] [ADDRESS] Guarantor: [GUARANTOR_NAME] Insurance: Highmark Medicare PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME] Appointment Facility: POTOMAC UROLOGY CENTER - Manassas 03/27/2026 Progress Notes: [PROVIDER_NAME], MD Reason for Appointment 1. Microscopic Hematuria History of Present Illness General Urology: 82y F NPC presents today for microscopic hematuria. Reports urinary frequency and urgency - not bothesome. No hx of kidney stones. She reports spasms. Never smoker. ----------------------------------------- Labs (02/2026): Cr 0.7 UAmicro (03/2026): WBC 40-60, RBC 3-10, Bac Many, CaOx Crystal UCX: Normal. Current Medications Taking Trelegy Ellipta Levothyroxine Sodium Estradiol Pantoprazole Sodium Entresto PARoxetine HCl Metoprolol Succinate ER Ibandronate Sodium Medication List reviewed and reconciled with the patient Past Medical History Thyroid disease. Depression. Surgical History thyroidectomy HYSTERECTOMY CARPAL TUNNEL shoulder replacement Family History Father: deceased Mother: deceased Progress Note: [PROVIDER_NAME], MD 03/27/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/16/2026 03:31 AM EDT 1/3 4/16/26, 12:31 AM Print Preview [PATIENT_NAME] DOB: [DOB] (82 yo F) Acc No. [ACCOUNT_ID] DOS: 03/27/2026 Social History Smoking: no Recreational drug use: no. Exercise: no. Caffeine: yes, frequency:2 cups of coffee per day. Sexually active: no. Occupation: no. Screening Allergies Penicillin: rash Hospitalization/Major Diagnostic Procedure Denies Past Hospitalization Review of Systems 12 system Review of Systems completed in the chart and all pertinent positives and negatives reviewed with the patient...fp. Vital Signs RR: 16, HR: 69, BP: 108/65 mm Hg, Ht: 60, Wt: 147 lbs, BMI: 28.71 Index. Assessments 1.Microscopic hematuria - R31.29 (Primary) 2.OAB (overactive bladder) - N32.81 Treatment 1.Microscopic hematuria LAB: Urinalysis, Complete With Microscopic Examination With Reflex to Urine Culture, Routine IMAGING: CT : Urogram (Abd/Pel) w/wo IV Contrast PROCEDURE: Bladder Scan/PVR (Performed Date - 03/27/2026) 12ml Notes: No GH, UTI, kidney stones. UAmicro (03/2026): WBC 40-60, RBC 3-10, Bac Many, CaOx Crystal UCX: Normal. She is a non smoker, but husband was a smoker (2nd hand exposure) s/p hysterectomy with sacrocolpopexy may or may not have pelvic mesh vs MUS Plan for CTU and Cysto 2.OAB (overactive bladder) Notes: Reports urinary frequency and urgency. This is a patient who comes into be evaluated for overactive bladder symptoms. We discussed various treatment options according to the AUA Guidelines for overactive bladder. First line treatment: Behavioral therapy (bladder training, bladder control strategies, pelvic floor muscle training, fluid management) Second line treatment: Medication (a